Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 4,405 | 203 | 982 | 1,661 | 3,673 |
| Cost of Goods | 908 | N/A | N/A | N/A | N/A |
| Gross Profit | 3,497 | 203 | 982 | 1,661 | 3,673 |
| Operating Expenses | 30,916 | 26,537 | 30,381 | 30,089 | 17,995 |
| Operating Income | -26,511 | -26,335 | -29,399 | -28,427 | -14,321 |
| Interest Expense | 460 | 929 | 910 | 733 | 336 |
| Other Income | 2,504 | 489 | 294 | 15,665 | -2,942 |
| Pre-tax Income | -24,467 | -26,775 | -30,015 | -13,495 | -17,600 |
| Income Tax | N/A | 99 | N/A | N/A | N/A |
| Net Income Continuous | -24,467 | -26,874 | -30,015 | -13,495 | -17,600 |
| Net Income | $-24,467 | $-26,874 | $-30,015 | $-13,495 | $-17,600 |
| EPS Basic Total Ops | -38.38 | -46.78 | -73.76 | -55.17 | -103.15 |
| EPS Basic Continuous Ops | -36.85 | -46.54 | -73.60 | -55.27 | -103.28 |
| EPS Diluted Total Ops | -38.38 | -46.78 | -73.76 | -55.17 | -103.15 |
| EPS Diluted Continuous Ops | -36.85 | -46.54 | -73.60 | -55.27 | -103.28 |
| EBITDA(a) | $-25,372 | $-24,891 | $-28,505 | $-27,682 | $-13,735 |